News
(Alliance News) - GSK PLC on Monday said its gepotidacin drug has been accepted for priority review in the US as an oral option for the treatment of a form of sexually transmitted infection gonorrhoea ...
Detailed price information for Ideaya Biosciences Inc (IDYA-Q) from The Globe and Mail including charting and trades.
The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.
3d
TipRanks on MSNGSK’s New Study on GSK5764227: A Potential Game-Changer in Gastrointestinal Cancer TreatmentGlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...
Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...
Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is ...
The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...
Despite the recent buzz, the effort to reduce animal testing in favor of NAMs has been underway for years. The VQN falls ...
Over 100 employees from GSK’s Hamilton site recently rolled up their sleeves for their annual "Together Days," a volunteer ...
GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results